Skip to content

What is the brand name for mequitazine?: A Look at an International Antihistamine

3 min read

Originally developed by French company Aventis, the drug mequitazine is commonly known by the brand name Primalan in many parts of the world. This medication is a second-generation antihistamine used to treat various allergic conditions, offering effective relief with a low potential for drowsiness compared to older alternatives.

Quick Summary

Mequitazine is a second-generation antihistamine primarily sold under the brand name Primalan in many countries. It is used to treat allergic conditions such as rhinitis and hives, with a lower risk of sedation than older antihistamines.

Key Points

  • Primary Brand Name: The main brand name for mequitazine is Primalan, particularly in European and international markets.

  • Antihistamine Type: Mequitazine is a second-generation antihistamine, meaning it is designed to cause less drowsiness than older, first-generation versions.

  • Treats Allergy Symptoms: It is used to relieve symptoms of allergic rhinitis (hay fever), urticaria (hives), and other allergic skin conditions.

  • Not Available in the US: The drug is not approved or sold in the United States, but it is available in other countries, including France and Japan.

  • Side Effects: Common side effects can include drowsiness, dizziness, and dry mouth, and caution is advised when operating machinery.

  • Mechanism of Action: Mequitazine works by blocking histamine from binding to H1 receptors, which prevents allergic symptoms from developing.

  • Low Sedation Profile: Unlike older antihistamines, mequitazine has a low propensity for sedation, similar to other modern, non-sedating drugs.

In This Article

Mequitazine brand names

While Primalan is the most widely recognized brand name for mequitazine, especially in Europe and other international markets, it is not the only one. Like many generic drugs, mequitazine has been marketed under different names depending on the country and pharmaceutical company. Some other alternative names include Mequitazyl, Metaplexan, Mircol, and Vigigan. It is important to note that mequitazine is not available in the United States, so these brand names are found in other countries.

What is mequitazine?

Mequitazine is an antihistamine belonging to the phenothiazine chemical class, developed in the 1970s. It is classified as a second-generation antihistamine, which means it was designed to be less sedating than older, first-generation antihistamines. Its primary function is to act as a histamine H1-receptor antagonist. In simpler terms, it blocks the effect of histamine, a natural chemical released by the body during an allergic reaction. This action provides relief from common allergy symptoms like itching, sneezing, and a runny nose.

Medical uses for mequitazine

Mequitazine's antihistamine properties make it a valuable treatment for a variety of allergic conditions. Its effectiveness is well-documented in clinical studies, and it is a mainstay in allergy treatment in many countries where it is available.

Common uses for mequitazine include:

  • Allergic rhinitis: A common allergy affecting the nose, often called hay fever. Mequitazine helps relieve sneezing, itching, and a runny or stuffy nose.
  • Urticaria (hives): This skin condition, characterized by red, itchy welts, can be effectively managed with mequitazine to reduce itching and redness.
  • Eczema and dermatitis: Mequitazine can help reduce the itching associated with these inflammatory skin conditions.
  • Allergic conjunctivitis: For eye-related allergy symptoms like itching and watering, mequitazine provides relief.

How mequitazine works in the body

When the body encounters an allergen, it releases histamine. Histamine then binds to H1 receptors throughout the body, triggering an allergic response. Mequitazine works by occupying these H1 receptors, blocking histamine from binding and preventing the cascade of allergic symptoms. This mechanism is crucial for mitigating the body's overreaction to harmless substances like pollen or pet dander. As a second-generation antihistamine, mequitazine is more selective for peripheral H1 receptors, which are located outside the central nervous system. This selectivity is the reason it causes significantly less drowsiness than first-generation antihistamines.

Comparison of mequitazine with other antihistamines

To better understand mequitazine's place in allergy treatment, it can be helpful to compare it with other common antihistamines. This comparison highlights its low-sedation profile, a major advantage for many users.

Feature Mequitazine (e.g., Primalan) Diphenhydramine (e.g., Benadryl) Cetirizine (e.g., Zyrtec) Loratadine (e.g., Claritin)
Generation Second First Second Second
Sedation Low High Low Low
Onset Fast Fast Fast Slower
Duration Long-acting Short-acting Long-acting Long-acting
Effectiveness Similar to others Potent Potent Potent
Availability Not in US, common in France, Japan Worldwide (OTC) Worldwide (OTC) Worldwide (OTC)
Mechanism Selective H1 antagonist Non-selective H1 antagonist Selective H1 antagonist Selective H1 antagonist

Potential side effects of mequitazine

While generally well-tolerated, mequitazine can cause side effects. The most commonly reported side effects include drowsiness, dizziness, and dry mouth. Less common but more serious side effects, though rare, can include liver dysfunction or blood disorders. It is important to discuss potential side effects with a healthcare professional, especially for individuals with pre-existing conditions like liver impairment or glaucoma, or for pregnant or breastfeeding women.

Important safety considerations

Like many medications, mequitazine requires careful use under certain circumstances. Combining mequitazine with alcohol can exacerbate drowsiness and impair coordination, and is therefore not advised. Patients should inform their doctor of all medications they are taking, as some, like monoamine oxidase inhibitors (MAOIs), can interact with mequitazine and increase the risk of side effects. Individuals with respiratory conditions like asthma or COPD should also use caution, as mequitazine can sometimes thicken mucus secretions.

Conclusion

For many people seeking relief from allergic conditions, mequitazine, under brand names like Primalan, represents an effective and less-sedating option compared to older antihistamines. While its availability is primarily outside of the US, its role as a second-generation H1 antagonist for treating issues like rhinitis and urticaria is well-established. As with any medication, understanding its uses, side effects, and proper safety considerations is crucial for effective treatment. Always consult with a healthcare professional before beginning any new medication to ensure it is the right choice for your specific needs.

Learn more about the pharmacology of antihistamines.

Frequently Asked Questions

The primary brand name for mequitazine is Primalan, though other trade names like Mequitazyl also exist.

No, mequitazine is not available for purchase or prescription in the United States.

Mequitazine is used to treat allergic conditions such as hay fever (allergic rhinitis), hives (urticaria), and itching associated with skin conditions.

Mequitazine is a second-generation antihistamine with a low-sedation profile, meaning it is less likely to cause drowsiness compared to older, first-generation antihistamines.

Common side effects include drowsiness, dizziness, incoordination, and dry mouth. More serious, but rarer, side effects may also occur.

It is not advisable to drive if you experience any drowsiness, dizziness, or impaired coordination after taking mequitazine. Patients should assess how they react to the medication before engaging in activities that require mental alertness.

Mequitazine is available in many countries outside the US, including France, Japan, and parts of Europe.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.